Strides Pharma Science Ltd. Investor Presentation

Investor Presentation

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

We would like to inform you that Management of Strides will be meeting investors/ analysts during the week of February 5, 2024. The investor deck which will be considered during these meetings is enclosed for your reference.

pdf

Strides Pharma Science Ltd. Investor Presentation

Strides Pharma Science Ltd. Investor Presentation: Get insights into company performance, financials, capex plans and more

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Investor Presentation

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Investor Presentation

The Nifty 50 has corrected from its August peak, but smallcap and midcap stocks are holding up. What is driving this?

The RBI kept interest rates unchanged again this August, meaning FDs and debt funds are still offering attractive, risk-free returns. But the stock market is volatile. What is your current mindset?

Nifty is in a tug of war, with the volatility index rising sharply. What do you think will drive market direction in July?

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Investor Presentation

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Investor Presentation